FJ Life Sciences Series Digital Temperature Gauge/Switch
The FJ DTG Digital Temperature gauge is specifically designed for Pharmaceutical and Biotech applications. The FJ DTG operates on field replaceable batteries and can be ordered with / without a secondary 100 ½ 3-wire RTD. The large LCD display makes viewing in process simple. All elements are provided with a permanently engraved stainless steel tag and a certificate of calibration and conformance.
- Models and fittings specifically designed for Pharmaceutical and Biotech applications
- Operates on field replaceable batteries; DC switching version available
- Large Liquid Crystal Display makes viewing easy and repeatable
- All models offer field calibration capability
- All programming and adjustments behind tamper-resistant back plate
At Liquidyne, we prioritize our commitment to quality and consistency. In 2017 we achieved ISO 9001:2015 Quality Management System certification to ensure we can repeatedly deliver consistently high-quality products and solutions. Being an ISO 9001 facility, together with our USP Class VI Testing, ASME Bioprocessing Equipment (BPE), and EHEDG certification guarantee, we have the methodologies to assure quality. We will quickly and accurately rectify any issues if any of our products are ever in non-conformance.
"Thanks so much! What a quick turn around. It is a pleasure working with Liquidyne."
Process Development Manager
"I received the cart yesterday, thanks for the fast delivery! It feels sturdy. I sat on it. It does not bounce. It is also easy to clean and wipe or wash down."
Vice President, Analytical Development and Manufacturing
"Thanks again for reacting so quickly and meeting me halfway with the element. We will be able to get installed and have things keep moving overnight with the night crew. The little things like this are always greatly appreciated when working with Liquidyne."
“This pump cut our processing time from 3 days to 1 shift. I’m not giving this pump back. You will have to come and get it if you want it... and that won’t likely happen.”
VP Antibody Manufacturing